ARIAD PHARMACEUTICALS INC's ticker is ARIA and the CUSIP is 04033A100. A total of 2 filers reported holding ARIAD PHARMACEUTICALS INC in Q3 2011. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2013 | $107,000 | -8.5% | 6,100 | 0.0% | 0.00% | 0.0% |
| Q1 2013 | $117,000 | +1.7% | 6,100 | +1.7% | 0.00% | 0.0% |
| Q4 2012 | $115,000 | -20.7% | 6,000 | 0.0% | 0.00% | -33.3% |
| Q3 2012 | $145,000 | +110.1% | 6,000 | +50.0% | 0.00% | +50.0% |
| Q2 2012 | $69,000 | -13.8% | 4,000 | -20.0% | 0.00% | 0.0% |
| Q1 2012 | $80,000 | -45.6% | 5,000 | -58.3% | 0.00% | -50.0% |
| Q4 2011 | $147,000 | -33.2% | 12,000 | -52.0% | 0.00% | -33.3% |
| Q3 2011 | $220,000 | -22.3% | 25,000 | 0.0% | 0.01% | -14.3% |
| Q2 2011 | $283,000 | – | 25,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sarissa Capital Management LP | 12,850,000 | $69,390,000 | 26.80% |
| Opaleye Management Inc. | 1,500,000 | $8,100,000,000 | 6.31% |
| Camber Capital Management LP | 6,000,000 | $32,400,000 | 3.04% |
| Ghost Tree Capital, LLC | 700,000 | $3,780,000 | 2.05% |
| Granite Point Capital Management, L.P. | 700,000 | $3,780,000 | 1.88% |
| Duquesne Family Office | 1,645,000 | $8,883,000 | 1.09% |
| Geduld E E | 272,200 | $1,470,000 | 1.04% |
| Elk Creek Partners, LLC | 659,232 | $3,560,000 | 0.93% |
| Palo Alto Investors LP | 2,231,717 | $12,051,000 | 0.90% |
| HighVista Strategies LLC | 1,200,000 | $6,480,000 | 0.87% |